ସର୍ଭିକାଲ୍ କ୍ୟାନ୍ସର

Systemic chemotherapy with or without palliative radiation represents the current standard of care in patients with recurrent or metastatic cervix cancer. In addition, pelvic radiotherapy including brachytherapy is also recommended. There is no consensus on the treatment of metastatic site in patients with oligo-metastatic or oligo-recurrent cervix cancer. Also, it is not clear if addition of local treatment to systemic chemotherapy benefits all patients with metastatic disease or a select few with limited systemic disease burden. It's presently unclear which patients derive maximum benefit wi…

Sponsor: ଟାଟା ମେମୋରିଆଲ୍ ହସ୍ପିଟାଲ୍
ClinicalTrials.gov ରେ NCT07400809
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ ୧୭ ଫେବୃଆରୀ ୨୦୨୬ · ଆମ ଦ୍ୱାରା ପଢ଼ାଯାଇଛି ୨୦ ଅକ୍ଟୋବର ୨୦୨୬